Limiting financial disincentives in live organ donation: A rational solution to the kidney shortage

American Journal of Transplantation

Volumn 6, Issue 11, 2006, Pages 2548-2555

  Gaston, R S ^a   Danovitch, G M ^b   Epstein, R A ^c,f   Kahn, J P ^d   Matas, A J ^d   Schnitzler, M A ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

Incentives; Kidney transplant; Living donor; Public policy

Indexed keywords

ACCURACY; ACT; COMPENSATION; FINANCIAL DISINCENTIVE; FINANCIAL MANAGEMENT; FOLLOW UP; HEALTH CARE AVAILABILITY; HEALTH CARE DISTRIBUTION; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LEGAL ASPECT; LIVING DONOR; LONG TERM CARE; NATIONAL ORGAN TRANSPLANT ACT; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; STANDARD; UNITED STATES;

COSTS AND COST ANALYSIS; FEES AND CHARGES; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MOTIVATION; NEPHRECTOMY; TISSUE AND ORGAN HARVESTING;

EID: 33750012851     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01492.x     Document Type: Review

References (48)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
2. Gaston RS, Alveranga DY, Becker BN et al. Kidney and pancreas transplantation. Am J Transplant 2003; 3(Suppl 4): 64-77.
3. University Renal Research and Education Association. 2005 Scientific Registry of Transplant Recipients Annual Data Report. 2006 [cited 2006 4/16/2006]; Available from: http://www.ustransplant.org
4. Epstein AM, Ayanian JZ, Keogh JH et al. Racial disparities in access to renal transplantation - clinically appropriate or due to underuse or overuse? N Engl J Med 2000; 343: 1537-1544.
5. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001; 12: 2753-2758.
6. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002; 74: 1377-1381.
7. Merion RM, Ashby VB, Wolfe RA et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294: 2726-2733.
8. Ojo AO, Hanson JA, Meier-Kriesche H et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589-597.
9. Reynolds G. Will any organ do? New York Times 2005 July 10, 2005.
10. Sheehy E, Conrad SL, Brigham LE et al. Estimating the number of potential organ donors in the United States. N Engl J Med 2003; 349: 667-674.
11. Abecassis M, Adams M, Adams P et al. Consensus statement on the live organ donor. JAMA 2000; 284: 2919-2926.
12. Delmonico F. Council of the Transplantation Society. A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: Data and Medical Guidelines. [see comment]. Transplantation 2005; 79(6 Suppl): S53-S66.
13. Delmonico FL, Graham WK. Direction of the organ procurement and transplantation network and united network for organ sharing regarding the oversight of live donor transplantation and solicitation for organs. Am J Transplant 2006; 6: 37-40.
14. Steinbrook R. Public solicitation of organ donors. N Engl J Med 2005; 353: 441-444.
15. Epstein R. Mortal Peril: Our Inalienable Right to Health Care? Reading, MA: Addison-Wesley, 1997.
16. Matas AJ. The case for living kidney sales: Rationale, objections and concerns. Am J Transplant 2004; 4: 2007-2017.
17. Delmonico FL, Arnold R, Scheper-Hughes N, Siminoff LA, Kahn J, Youngner SJ. Ethical incentives - not payment - for organ donation. N Engl J Med 2002; 346: 2002-2005.
18. Institute of Medicine, Committee on Increasing Rates of Organation. In: Childress JF, Liverman CT, eds. Organ Donation: Opportunities for Action. Washington, DC: The National Academies Press, 2006: 1-18.
19. Plant WD. Is it desirable to legitimize paid living donor kidnry transplantation programmes? Part 2: Evidence against. In: Gaston RS, Wadstrom J, eds. Living Donor Kidney Transplantation: Current Practice, Emerging Trends and Evolving Challenges. London: Taylor and Francis, 2005:181-190.
20. Meier-Kriesche HU, Schold JD, Gaston RS, Wadstrom J, Kaplan B. Kidneys from deceased donors: Maximizing the value of a scarce resource. Am J Transplant 2005; 5: 1725-1730.
21. U.S. Department of Health and Human Services. Organ Donation Breakthrough Collaborative: From Best Practice to Common Practice. 2005. Accessed 1/27/2006 at http://organdonation.iqsolutions.com.
22. Matas AJ, Schnitzler M. Payment for living donor (vendor) kidneys: A cost-effectiveness analysis. Am J Transplant 2004; 4: 216-221.
23. Murphy K, Topel R. Diminishing returns?: The costs and benefits of improving health. Perspect Biol Med 2003; 46: S108-S128.
24. Cecka JM. The OPTN/UNOS renal transplant registry. In: Cecka JM, Terasaki PI, eds. Clinical Transplants 2004. Los Angeles: UCLA Tissue Typing Laboratory, 2005:1-15.
25. Bay WH, Hebert LA. The living donor in kidney transplantation. Ann Intern Med 1987; 106: 719-727.
26. Matas AJ, Bartlett ST, Leichtman AB, Delmonico FL. Morbidity and mortality after living kidney donation, 1999-2001: Survey of United States transplant centers. Am J Transplant 2003; 3: 830-834.
27. Fehrman-Ekholm I, Thiel G. Long-term risks after living kidney donation. In: Gaston RS, Wadstrom J, eds. Living Donor Kidney Transplantation: Current Practice, Emerging Trends and Evolving Challenges. London: Taylor and Francis, 2005:99-112.
28. Ramcharan T, Matas AJ. Long-term (20-37 years) follow-up of living kidney donors. Am J Transplant 2002; 2: 959-964.
29. Thiel G, Nolte C, Tsinalis D. Living kidney donors with isolated medical abnormalities: The SOL-DHR experience. In: Gaston RS, Wadstrom J, eds. Living Donor Kidney Transplantation: Current Practice, Emerging Trends and Evolving Challenges. London: Taylor and Francis, 2005: 55-73.
30. Ellison MD, McBride MA, Taranto SE, Delmonico FL, Kauffman HM. Living kidney donors in need of kidney transplants: A report from the organ procurement and transplantation network. Transplantation 2002; 74: 1349-1351.
31. Johnson EM, Remucal MJ, Gillingham KJ, Dahms RA, Najarian JS, Matas AJ. Complications and risks of living donor nephrectomy. Transplantation 1997; 64: 1124-1128.
32. Johnson EM, Anderson JK, Jacobs C et al. Long-term follow-up of living kidney donors: Quality of life after donation. Transplantation 1999; 67: 717-721.
33. Hiller J, Sroka M, Weber R, Morrison AS, Ratner LE. Identifying donor concerns to increase live organ donation. J Transpl Coord 1998; 8: 51-54.
34. Knotts RS, Finn WF, Armstrong T. Psychosocial factors impacting patients, donors, and nondonors involved in renal transplant evaluation. Kidney Found Perspect 1996; 15: 11-23.
35. LaPointe Rudow D, O'Rourke M, Musat C, Garvey CA, Gish-Panjada D, Alexander C. Living donor insurability and its impact on donor health care. World Transplant Congress, Boston, MA, July 2006. Abstract #1192.
36. Murray JE, Merrill JP, Harrison JH. Renal homotransplantation in identical twins. Surg Forum 1955; 6: 432-436.
37. Steiger J, McCune TR. Financial and insurance considerations for living donors. In: Gaston RS, Wadstrom J, eds. Living donor Kidney Transplantation: Current Practices, Emerging Trends, and Evolving Challenges. London: Taylor and Francis, 2005:165-170.
38. Scientific Registry of Transplant Recipients, personal communication from FK Port, October, 2005.
39. Centers for Medicare and Medicaid Services. Centers for Medicare and Medicaid Services Workers' Compensation Medicare Set-aside Proposal Requirements Checklist. Accessed 10/12/2005 at http://www.cms.hhs.gov/medicare/cob/pdf/ wechecklist.
40. Field MJ, Lawrence RL, Zwanziger L, eds. Extending Medicare Coverage for Preventive and Other Services. Washington, DC: National Academy Press, 2000.
41. Fehrman-Eckholm I. The psychosocial impact of donor nephrectomy. In: Gaston RS, Wadstrom J, eds. Living Donor Kidney Transplantation: Current Practices, Emerging Trends, and Evolving Challenges. London: Taylor & Francis, 2005:113-117.
42. Price DPT. Legal and ethical dilemmas in living donor kidney transplantation. In: Gaston RS, Wadstrom J, eds. Living Donor Kidney Transplantation: Current Practices, Emerging Trends, and Evolving Challenges. London: Taylor & Francis, 2005:157-164.
43. Delmonico FL. Reply to letter to the editor. N Engl J Med 2004; 351: 937.
44. P.L. 106-56: Organ Donor Leave Act. 1999. Accessed 10/07/2005 at http://www.a-s-t.org/PublicPolicy/OrganDonation_pdfs/Donpl10656.pdf.
45. Health Resources and Services Administration (HRSA) H. Extramural support program for reimbursement of travel and subsistence expenses incurred toward living organ donations. Federal Register 2005; 70: 59760-59762.
46. United Network for Organ Sharing. Financial aspects: State tax deductions and donor leave laws. 2005. Accessed 10/10/2005 at http://www.transplantliving. org/livingdonation/financialaspects/statetax.aspx
47. Adams PL, Cohen DJ, Danovitch GM et al. The nondirected live-kidney donor: Ethical considerations and practice guidelines: A National Conference Report. Transplantation 2002; 74: 582-589.
48. Radcliffe-Richards J. Nepharious goings on: Kidney sales and moral arguments. J Med Philos 1996; 21: 375-416.